Atovaquone/proguanil resistance in Africa: A case report
10.1080/00365540310016862. 14723376
Atovaquone/proguanil resistance in Africa: a case report. KP David M Alifrangis A Salanti LS Vestergaard A Ronn IB Bygbjerg, Scand J Infect Dis 2003 35 897 898 10.1080/00365540310016862 14723376
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: Case reports
12649236. 10.1136/bmj.326.7390.628
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. A Farnert J Lindberg P Gil G Swedberg Y Berqvist MM Thapar N Lindegardh S Berezcky A Bjorkman, Bmj 2003 326 628 629 12649236 10.1136/bmj.326.7390.628
Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria
12057021. 10.1186/1475-2875-1-1
Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. QL Fivelman GA Butcher IS Adagu DC Warhurst G Pasvol, Malar J 2002 1 1 12057021 10.1186/1475-2875-1-1
Polymerase chain reaction and molecular genotyping to monitor parasitological response to anti-malarial chemotherapy in the Peruvian Amazon
16606982
Polymerase chain reaction and molecular genotyping to monitor parasitological response to anti-malarial chemotherapy in the Peruvian Amazon. E Ayala AG Lescano RH Gilman M Calderon VV Pinedo H Terry L Cabrera JM Vinetz, Am J Trop Med Hyg 2006 74 546 553 16606982
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: Comparison of results based on genotyping of msp-1, msp-2, and glurp
12641400
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. A Cattamanchi D Kyabayinze A Hubbard PJ Rosenthal G Dorsey, Am J Trop Med Hyg 2003 68 133 139 12641400
Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO, Geneva: World Health Organization 2003
The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment
10.1016/S0169-4758(98)01340-4
The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. G Snounou HP Beck, Parasitology Today 1998 14 11 10.1016/S0169-4758(98)01340-4
Medicines for Malaria Venture and World Health Organization
Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May Amsterdam, The Netherlands. Anon, Medicines for Malaria Venture and World Health Organization 2008
PCR detection of Plasmodium falciparum in human urine and saliva samples
17092335. 10.1186/1475-2875-5-103
PCR detection of Plasmodium falciparum in human urine and saliva samples. S Mharakurwa C Simoloka PE Thuma CJ Shiff DJ Sullivan, Malar J 2006 5 103 17092335 10.1186/1475-2875-5-103
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa
7611566
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. CV Plowe A Djimde M Bouare O Doumbo TE Wellems, Am J Trop Med Hyg 1995 52 565 568 7611566
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand
10.1016/S0035-9203(99)90120-7. 10674079
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. G Snounou X Zhu N Siripoon W Jarra S Thaithong KN Brown S Viriyakosol, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079